KRAS and lung adenocarcinoma: There were significant differences in the T and N stages of TCGA lung adenocarcinoma and gender (P < 0.001), but there were no significant differences in M stage, age, smoking status, TP53 status, and KRAS status, and the relevant data were not statistically significant (P > 0.05) (Figure 6).